Safety and efficacy of basal bolus and premixed insulin intensification regimes in the management of type 2 diabetes mellitus : A 13 year narrative review of literature

Background: Type 2 Diabetes Mellitus (T2DM) is a chronic condition due to insulin resistance or relative insulin deficiency. Although insulin intensification regimens are commonly prescribed for the management of T2DM, there is uncertainty regarding their optimal use. We conducted a 13 Year narrativ...

Full description

Bibliographic Details
Main Authors: Penwalla, NI, Othman, Noordin, MN, Norilyani, Nik Ahmad, Nik Nur Fatnoon
Format: Article
Language:English
Published: Malaysian Pharmaceutical Society 2014
Subjects:
Online Access:http://irep.iium.edu.my/66667/
http://irep.iium.edu.my/66667/
http://irep.iium.edu.my/66667/1/FAPA%202014%20-%20BB%20Vs%20PM%20-%20MJP%20HPP%2004%20Page%20132.pdf
id iium-66667
recordtype eprints
spelling iium-666672019-01-25T07:41:07Z http://irep.iium.edu.my/66667/ Safety and efficacy of basal bolus and premixed insulin intensification regimes in the management of type 2 diabetes mellitus : A 13 year narrative review of literature Penwalla, NI Othman, Noordin MN, Norilyani Nik Ahmad, Nik Nur Fatnoon RC648 Specialties of Internal Medicine-Diseases of The Endocrine Glands. Clinical Endocrinology Background: Type 2 Diabetes Mellitus (T2DM) is a chronic condition due to insulin resistance or relative insulin deficiency. Although insulin intensification regimens are commonly prescribed for the management of T2DM, there is uncertainty regarding their optimal use. We conducted a 13 Year narrative review to compare outcomes of these regimens in the treatment of T2DM. Method: We searched electronic databases (PubMed, Scopus, Proquest and Google Search), and “grey literature” from January 2000 to December 2013 to identify studies comparing insulin intensification regimens. Results: Out of 17 studies identified, we only included 10 studies specifically comparing Basal-Bolus regimens (BB) versus Pre-mixed Insulin Regimens (PM). Seven trials comparing regimens other than the studied regimens; with study duration lesser than 12 weeks; or involving Type 1 diabetes mellitus patients were excluded. The outcomes measured were divided into safety and efficacy parameters. Among the safety outcomes measured were Hypoglycemia, Weight Gain, Quality of Life (QoL), and other Adverse Events (AE). Whereas, efficacy outcomes measured were Glycosylated Haemoglobin (HbA1c), Fasting Plasma Glucose, Daily Plasma Glucose, Post Prandial Plasma Glucose, Carotid Intima Media Thickness (IMT), Adinopectin Level, 1-5-anhydroglucitol(1,5-AG),Total Daily Insulin (TDI) Dose and Cost. Mixed results were discovered among all the parameters measured favoring in between BB and PM regimens. Conclusion: We found that BB regimens showed better glycemic control especially in terms of the primary endpoint of HbAlc but at the expanse of significantly higher TDI dose, weight gain, and further increase in cost of treatment. Whereas, all other parameters measured were comparable between regimens. Locally, conventional human insulin is still the mainstay of insulin therapy in health facilities nationwide. Yet, none of the identified studies compared head-to-head human insulin in both arms. Thus, future researches comparing non-analogue insulin may be conducted to gather new evidence in the field of diabetes locally. Malaysian Pharmaceutical Society 2014-10 Article PeerReviewed application/pdf en http://irep.iium.edu.my/66667/1/FAPA%202014%20-%20BB%20Vs%20PM%20-%20MJP%20HPP%2004%20Page%20132.pdf Penwalla, NI and Othman, Noordin and MN, Norilyani and Nik Ahmad, Nik Nur Fatnoon (2014) Safety and efficacy of basal bolus and premixed insulin intensification regimes in the management of type 2 diabetes mellitus : A 13 year narrative review of literature. Malaysian Journal of Pharmacy, 1 (11). http://www.mps.org.my/
repository_type Digital Repository
institution_category Local University
institution International Islamic University Malaysia
building IIUM Repository
collection Online Access
language English
topic RC648 Specialties of Internal Medicine-Diseases of The Endocrine Glands. Clinical Endocrinology
spellingShingle RC648 Specialties of Internal Medicine-Diseases of The Endocrine Glands. Clinical Endocrinology
Penwalla, NI
Othman, Noordin
MN, Norilyani
Nik Ahmad, Nik Nur Fatnoon
Safety and efficacy of basal bolus and premixed insulin intensification regimes in the management of type 2 diabetes mellitus : A 13 year narrative review of literature
description Background: Type 2 Diabetes Mellitus (T2DM) is a chronic condition due to insulin resistance or relative insulin deficiency. Although insulin intensification regimens are commonly prescribed for the management of T2DM, there is uncertainty regarding their optimal use. We conducted a 13 Year narrative review to compare outcomes of these regimens in the treatment of T2DM. Method: We searched electronic databases (PubMed, Scopus, Proquest and Google Search), and “grey literature” from January 2000 to December 2013 to identify studies comparing insulin intensification regimens. Results: Out of 17 studies identified, we only included 10 studies specifically comparing Basal-Bolus regimens (BB) versus Pre-mixed Insulin Regimens (PM). Seven trials comparing regimens other than the studied regimens; with study duration lesser than 12 weeks; or involving Type 1 diabetes mellitus patients were excluded. The outcomes measured were divided into safety and efficacy parameters. Among the safety outcomes measured were Hypoglycemia, Weight Gain, Quality of Life (QoL), and other Adverse Events (AE). Whereas, efficacy outcomes measured were Glycosylated Haemoglobin (HbA1c), Fasting Plasma Glucose, Daily Plasma Glucose, Post Prandial Plasma Glucose, Carotid Intima Media Thickness (IMT), Adinopectin Level, 1-5-anhydroglucitol(1,5-AG),Total Daily Insulin (TDI) Dose and Cost. Mixed results were discovered among all the parameters measured favoring in between BB and PM regimens. Conclusion: We found that BB regimens showed better glycemic control especially in terms of the primary endpoint of HbAlc but at the expanse of significantly higher TDI dose, weight gain, and further increase in cost of treatment. Whereas, all other parameters measured were comparable between regimens. Locally, conventional human insulin is still the mainstay of insulin therapy in health facilities nationwide. Yet, none of the identified studies compared head-to-head human insulin in both arms. Thus, future researches comparing non-analogue insulin may be conducted to gather new evidence in the field of diabetes locally.
format Article
author Penwalla, NI
Othman, Noordin
MN, Norilyani
Nik Ahmad, Nik Nur Fatnoon
author_facet Penwalla, NI
Othman, Noordin
MN, Norilyani
Nik Ahmad, Nik Nur Fatnoon
author_sort Penwalla, NI
title Safety and efficacy of basal bolus and premixed insulin intensification regimes in the management of type 2 diabetes mellitus : A 13 year narrative review of literature
title_short Safety and efficacy of basal bolus and premixed insulin intensification regimes in the management of type 2 diabetes mellitus : A 13 year narrative review of literature
title_full Safety and efficacy of basal bolus and premixed insulin intensification regimes in the management of type 2 diabetes mellitus : A 13 year narrative review of literature
title_fullStr Safety and efficacy of basal bolus and premixed insulin intensification regimes in the management of type 2 diabetes mellitus : A 13 year narrative review of literature
title_full_unstemmed Safety and efficacy of basal bolus and premixed insulin intensification regimes in the management of type 2 diabetes mellitus : A 13 year narrative review of literature
title_sort safety and efficacy of basal bolus and premixed insulin intensification regimes in the management of type 2 diabetes mellitus : a 13 year narrative review of literature
publisher Malaysian Pharmaceutical Society
publishDate 2014
url http://irep.iium.edu.my/66667/
http://irep.iium.edu.my/66667/
http://irep.iium.edu.my/66667/1/FAPA%202014%20-%20BB%20Vs%20PM%20-%20MJP%20HPP%2004%20Page%20132.pdf
first_indexed 2023-09-18T21:34:40Z
last_indexed 2023-09-18T21:34:40Z
_version_ 1777412741165744128